tirzepatide clinical trial results ABCD Audit Tirzepatide cardiovascular event risk assessment:

While this has not been confirmed in humans, retatrutide, like semaglutide and tirzepatide, is generally not recommended for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

Regulatory & Medical Community Viewpoint (2025) The leading dermatology and pharmacology reviews caution against parenteral (IV/IM) glutathione for cosmetic skin-lightening citing lack of robust evidence and significant safety concerns

Document any immediate post-injection monitoring

Leptin, produced by fat cells, influences brain regions involved in reward and motivation